High-resolution computed tomography characterization of interstitial lung diseases in polymyositis/dermatomyositis

Journal of Rheumatology

Volumn 35, Issue 2, 2008, Pages 260-269

  Hayashi, Shinichiro ^a,b   Tanaka, Masahide ^a,b   Kobayashi, Hiromi ^a,b   Nakazono, Takahiko ^a,c   Satoh, Toshimi ^a,d   Fukuno, Yuji ^a,b   Aragane, Naoko ^a,b   Tada, Yoshifumi ^a,d   Koarada, Shuichi ^a,d   Ohta, Akihide ^a,d   Nagasawa, Kohei ^a,d  

^a SAGA UNIVERSITY   (Japan)

^b Pulmonary Medicine

^c Radiology   (Australia)

^d Pathology ^*

Author keywords

Dermatomyositis; Interstitial lung disease; Polymyositis

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL FEATURE; DEATH; DERMATOMYOSITIS; DISEASE COURSE; FEMALE; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; INTERSTITIAL LUNG DISEASE; LUNG FIBROSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; POLYMYOSITIS; PRIORITY JOURNAL; RESPIRATORY FAILURE;

ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; DERMATOMYOSITIS; DISEASE PROGRESSION; FEMALE; HISTOCYTOCHEMISTRY; HUMANS; KAPLAN-MEIERS ESTIMATE; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 39549115485     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Takizawa H, Shiga J, Moroi Y, Miyachi S, Nishiwaki M, Miyamoto T. Interstitial lung disease in dermatomyositis: clinicopathological study. J Rheumatol 1987;14:102-7.
2. Tazelaar HD, Viggiano RW, Pickersgill J, Colby TV. Interstitial lung disease in polymyositis and dermatomyositis; clinical features and prognosis as correlated with histologic findings. Am Rev Respir Dis 1990;141:727-33.
3. Nawata Y, Kurasawa K, Takabayashi K, et al. Corticosteroid-resistant interstitial pneumonitis in dermatomyositis/polymyositis: prediction and treatment with cyclosporine. J Rheumatol 1999;26:1527-33.
4. Marie I, Hachulla E, Cherin P, et al. Interstitial lung disease in polymyositis and dermatomyositis. Arthritis Rheum 2002;47:614-22.
5. Schnabel A, Reuter M, Biederer J, Richter C, Gross WL. Interstitial lung disease in polymyositis and dermatomyositis: clinical course and response to treatment. Semin Arthritis Rheum 2003;32:273-84.
6. Fathi M, Dastmalchi M, Rasmussen E, Lundberg IE, Tornling G. Interstitial lung disease, a common manifestation of newly diagnosed polymyositis and dermatomyositis. Ann Rheum Dis 2004;63:297-301.
7. Selva-O'Callaghan A, Labrador-Horrillo M, Munos-Gall X, et al. Polymyositis/dermatomyositis-associated lung disease: analysis of a series of 81 patients. Lupus 2005;14:534-42.
8. Bohan A, Peter JB. Polymyositis and dermatomyositis (first and second of 2 parts). N Engl J Med 1975;292:344-7.
9. Faul F, Erdfelder E, Lang AG, Buchner A. G*Power 3: A flexible Statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 2007;39:175-91.
10. Dupont WD, Plummer WD. PS power and sample size program available for free on the Internet. Controlled Clin Trials 1997;18:274.
11. Saag KG, Kline JN, Hunnighake GW. Idiopathic inflammatory myopathy. Interstitial lung diseases. In: Baum GL, Crapo JD, Celli BR, Karlinsky JB, editors. Textbook of pulmonary diseases. 6th ed. New York: Lippincott-Raven; 1988:360-3.
12. Ito M, Kaise S, Suzuki S, et al. Clinical-laboratory characteristics of patients with dermatomyositis accompanied by rapidly progressive interstitial lung disease. Clin Rheumatol 1999;18:462-7.
13. Fudman EJ, Schnitzer TJ. Dermatomyositis without creatinine kinase elevation. A poor prognostic sign. Am J Med 1986;80:329-32.
14. Takada T, Suzuki E, Nakano M, et al. Clinical features of polymyositis/dermatomyositis with steroid-resistant interstitial lung disease. Intern Med 1998;37:669-73.
15. Benbassat J, Gefel D, Larholt K, Sukenik S, Morgenstern V, Zlotnick A. Prognostic factors in polymyositis/dermatomyositis. Arthritis Rheum 1985;28:249-55.
16. Kurasawa K, Nawata Y, Takabayashi K, et al. Activation of pulmonary T cells in corticosteroid-resistant and -sensitive interstitial pneumonitis in dermatomyositis/polymyositis. Clin Exp Immunol 2002;129:541-8.
17. Kissel JT, Mendell JR, Rammohan KW. Microvascular deposition of complement membrane attack complex in dermatomyositis. N Engl J Med 1986;314:329-34.
18. Dalakas MC. Immunopathogenesis of inflammatory myopathies. Ann Neurol 1995;37 Suppl 1:S74-S86.
19. Amato AA, Barohn RJ. Idiopathic inflammatory myopathies. Neurol Clin 1997;15:615-48.
20. Hilton-Jones D. Inflammatory muscle diseases. Curr Opin Neurol 2001;14:591-6.
21. Kikuchi Y, Koarada S, Tada Y, et al. Difference in B cell activation between dermatomyositis and polymyositis; analysis of the expression of RP105 on peripheral blood B cells. Ann Rheum Dis 2001;60:1137-40.
22. Fujisawa T, Nakamura Y, Enomoto N, et al. Differences in clinical features and prognosis of interstitial lung diseases between polymyositis and dermatomyositis. J Rheumatol 2005;32:58-64.
23. Tansey D, Wells AU, Colby TV, et al. Variations in histological patterns of interstitial pneumonia between connective tissue disorders and their relationship to prognosis. Histopathology 2004;44:585-96.
24. Wittram C, Mark EJ, McLoud TC. CT-histologic correlation of the ATS/ERS 2002 classification of idiopathic interstitial pneumonia. RadioGraphics 2003;23:1057-71.
25. Akira M, Hara H, Sakatani M. Interstitial lung disease in association with polymyositis-dermatomyositis: long-term follow-up CT evaluation in seven patients. Radiology 1999;210:333-8.
26. Douglas WM, Tazelaar HD, Hartman TE, et al. Polymyositis-dermatomyositis- associated interstitial lung disease. Am J Respir Crit Care Med 2001;164:1182-5.
27. Cottin V, Thivolet-Bejui F, Reynaud-Gaubert M, et al. Interstitial lung disease in amyopathic dermatomyositis, dermatomyositis and polymyositis. Eur Respir J 2003;22:245-50.
28. Matsushita T, Hasegawa M, Fujimoto M, et al. Clinical evaluation of anti-aminoacyl tRNA synthetase antibodies in Japanese patients with dermatomyositis. J Rheumatol 2007;34:1012-8.